Showing 1 - 13 results of 13 for search 'Christine Lebrun', query time: 0.04s
Refine Results
-
1
Creating safe spaces: lessons from South Africa and Burundi by Christine Lebrun, Katharine Derderian
Published 2007-01-01
Article -
2
Kappa Free Light Chains, Soluble Interleukin-2 Receptor, and Interleukin-6 Help Explore Patients Presenting With Brain White Matter Hyperintensities by Michael Levraut, Michael Levraut, Cassandre Landes, Lydiane Mondot, Lydiane Mondot, Lydiane Mondot, Mikael Cohen, Mikael Cohen, Saskia Bresch, Vesna Brglez, Vesna Brglez, Barbara Seitz-Polski, Barbara Seitz-Polski, Christine Lebrun-Frenay, Christine Lebrun-Frenay
Published 2022-03-01
Article -
3
-
4
The diagnostic value of the central vein sign in radiologically isolated syndrome by Cassandre Landes‐Chateau, Michael Levraut, Darin T. Okuda, Albert Themelin, Mikael Cohen, Orhun H. Kantarci, Aksel Siva, Daniel Pelletier, Lydiane Mondot, Christine Lebrun‐Frenay, on behalf RISConsortium
Published 2024-03-01
Article -
5
Peripheral facial palsy following COVID-19 vaccination: a practical approach to use the clinical situation as a guide by Claire Foirest, Kévin Bihan, Frédéric Tankéré, Helga Junot, Sophie Demeret, Rabab Debs, Elisabeth Maillart, Christine Lebrun-Frenay, Augustin Vigouroux, Maxime Caudron, Etienne Canouï, Georges Lamas, Nicolas Weiss, Valérie Pourcher
Published 2022-06-01
Article -
6
HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Disorders (HAND) by Marie-Lise Gougeon, Béatrice Poirier-Beaudouin, Jacques Durant, Christine Lebrun-Frenay, Héla Saïdi, Valérie Seffer, Michel Ticchioni, Stephane Chanalet, Helene Carsenti, Alexandra Harvey-Langton, Muriel Laffon, Jacqueline Cottalorda, Christian Pradier, Pierre Dellamonica, Matteo Vassallo
Published 2017-02-01
Article -
7
Erratum to ‘HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Disorders (HAND)’ by Marie-Lise Gougeon, Béatrice Poirier-Beaudouin, Jacques Durant, Christine Lebrun-Frenay, Héla Saïdi, Valérie Seffer, Michel Ticchioni, Stephane Chanalet, Helene Carsenti, Alexandra Harvey-Langton, Muriel Laffon, Jacqueline Cottalorda, Christian Pradier, Pierre Dellamonica, Matteo Vassallo
Published 2017-03-01
Article -
8
Excess Mortality in Patients with Multiple Sclerosis Starts at 20 Years from Clinical Onset: Data from a Large-Scale French Observational Study. by Emmanuelle Leray, Sandra Vukusic, Marc Debouverie, Michel Clanet, Bruno Brochet, Jérôme de Sèze, Hélène Zéphir, Gilles Defer, Christine Lebrun-Frenay, Thibault Moreau, Pierre Clavelou, Jean Pelletier, Eric Berger, Philippe Cabre, Jean-Philippe Camdessanché, Shoshannah Kalson-Ray, Christian Confavreux, Gilles Edan
Published 2015-01-01
Article -
9
Double-Blind Controlled Randomized Trial of Cyclophosphamide versus Methylprednisolone in Secondary Progressive Multiple Sclerosis. by Bruno Brochet, Mathilde S A Deloire, Paul Perez, Timothé Loock, Louise Baschet, Marc Debouverie, Sophie Pittion, Jean-Christophe Ouallet, Pierre Clavelou, Jérôme de Sèze, Nicolas Collongues, Patrick Vermersch, Hélène Zéphir, Giovanni Castelnovo, Pierre Labauge, Christine Lebrun, Mikael Cohen, Aurélie Ruet, PROMESS study investigators
Published 2017-01-01
Article -
10
Real-World Effectiveness of Natalizumab Extended Interval Dosing in a French Cohort by Juliette Pelle, Anais R. Briant, Pierre Branger, Nathalie Derache, Charlotte Arnaud, Christine Lebrun-Frenay, Mikael Cohen, Lydiane Mondot, Jerome De Seze, Kevin Bigaut, Nicolas Collongues, Laurent Kremer, Damien Ricard, Flavie Bompaire, Charlotte Ohlmann, Magali Sallansonnet-Froment, Jonathan Ciron, Damien Biotti, Beatrice Pignolet, Jean-Jacques Parienti, Gilles Defer
Published 2023-02-01
Article -
11
Outcome and risk of recurrence in a large cohort of idiopathic longitudinally extensive transverse myelitis without AQP4/MOG antibodies by Elisabeth Maillart, Françoise Durand-Dubief, Céline Louapre, Bertrand Audoin, Bertrand Bourre, Nathalie Derache, Jonathan Ciron, Nicolas Collongues, Jérome de Sèze, Mikael Cohen, Christine Lebrun-Frenay, Nawel Hadhoum, Hélène Zéphir, Romain Deschamps, Clarisse Carra-Dallière, Pierre Labauge, Philippe Kerschen, Alexis Montcuquet, Sandrine Wiertlewski, David Laplaud, Gwenaëlle Runavot, Sandra Vukusic, Caroline Papeix, Romain Marignier, on behalf of the OFSEP, SFSEP, and NOMADMUS study groups
Published 2020-04-01
Article -
12
Effects of socioeconomic status on excess mortality in patients with multiple sclerosis in France: A retrospective observational cohort studyResearch in context by Sarah Wilson, Floriane Calocer, Fabien Rollot, Mathieu Fauvernier, Laurent Remontet, Laure Tron, Sandra Vukusic, Emmanuelle Le Page, Marc Debouverie, Jonathan Ciron, Aurélie Ruet, Jérôme De Sèze, Hélène Zephir, Thibault Moreau, Christine Lebrun-Frénay, David-Axel Laplaud, Pierre Clavelou, Pierre Labauge, Eric Berger, Jean Pelletier, Olivier Heinzlef, Eric Thouvenot, Jean Philippe Camdessanché, Emmanuelle Leray, Olivier Dejardin, Gilles Defer
Published 2023-01-01
Article -
13
Radiologically isolated syndrome: 5-year risk for an initial clinical event. by Darin T Okuda, Aksel Siva, Orhun Kantarci, Matilde Inglese, Ilana Katz, Melih Tutuncu, B Mark Keegan, Stacy Donlon, Le H Hua, Angela Vidal-Jordana, Xavier Montalban, Alex Rovira, Mar Tintoré, Maria Pia Amato, Bruno Brochet, Jérôme de Seze, David Brassat, Patrick Vermersch, Nicola De Stefano, Maria Pia Sormani, Daniel Pelletier, Christine Lebrun, Radiologically Isolated Syndrome Consortium (RISC), Club Francophone de la Sclérose en Plaques (CFSEP)
Published 2014-01-01
Article